节点文献
酮替芬联合孟鲁司特对咳嗽变异性哮喘患儿肺功能及炎症因子的影响
Effects of ketotifen combined with montelukast on pulmonary function and inflammatory factors in children with cough variant asthma
【摘要】 目的:探究酮替芬联合孟鲁司特对咳嗽变异性哮喘(CVA)患儿肺功能及炎症因子的影响。方法:62例CVA患儿分为对照组和观察组,每组各31例。对照组治疗予以孟鲁司特,观察组予以酮替芬联合孟鲁司特。比较两组患儿临床疗效及治疗前后咳嗽症状评分、肺功能[1s用力呼气容积(FEV1)、呼气峰值流速(PEF)、 FEV1占用力肺活量百分比(FEV1/PVC)]、炎症因子[白细胞介素-5(IL-5)、肿瘤坏死因子-α(TNF-α)、血清淀粉样蛋白A(SAA)、骨膜蛋白]水平,并观察两组患儿不良反应。结果:观察组患儿临床总有效率高于对照组(P<0.05)。治疗后,与对照组相比,观察组日间和夜间咳嗽症状积分更低,FEV1、PEF、FEV1/PVC上调程度及血清IL-5、TNF-α、SAA、骨膜蛋白水平下调程度均更大(P<0.05)。两组药物不良反应总发生率比较,差异无统计学意义(P>0.05)。结论:酮替芬联合孟鲁司特对咳嗽变异性哮喘患儿临床疗效良好,可有效改善咳嗽症状,增强肺功能,减轻炎症反应,且安全性好。
【Abstract】 Objective:To explore the effects of ketotifen combined with montelukast on pulmonary function and inflammatory factors in children with cough variant asthma.Methods:A total of 62 children with cough variant asthma were randomly divided into control group(n=31) and observation group(n=31).The control group was treated with montelukast and the observation group was treated with ketotifen combined with montelukast.The clinical efficacy,cough symptom score,pulmonary function [1 s forced expiratory volume(FEV1),peak expiratory flow rate(PEF),percentage of 1 s forced expiratory volume to forced vital capacity(FEV1/PVC)],inflammatory factors [interleukin-5(IL-5),tumor necrosis factor-α(TNF-α),serum amyloid A(SAA),periosteal protein] were compared between the two groups before and after treatment,and the adverse reactions of the two groups were observed.Results:The total clinical effective rate of the observation group was significantly higher than that of the control group(P<0.05).After treatment,the scores of daytime and nocturnal cough symptoms in the observation group were lower than those in the control group,and the up-regulated levels of FEV1,PEF,FEV1/PVC and the levels of serum IL-5,TNF-α,SAA and periosteal protein in the observation group were significantly lower than those in the control group(P<0.05).There was no significant difference in the total incidence of adverse drug reactions between the two groups(P>0.05).Conclusion:Ketotifen combined with montelukast is effective in the treatment of children with cough variant asthma,which can effectively improve cough symptoms,enhance lung function,and reduce inflammatory reaction,with higher safety.
【Key words】 Cough variant asthma; Ketotifen; Montelukast; Lung function; Inflammatory factors;
- 【文献出处】 川北医学院学报 ,Journal of North Sichuan Medical College , 编辑部邮箱 ,2021年01期
- 【分类号】R725.6
- 【被引频次】3
- 【下载频次】53